CENTRAL SEROUS CHORIORETINOPATHY FOLLOWING ORAL USE OF TADALAFIL
Journal: International Journal of Advanced Research (Vol.12, No. 02)Publication Date: 2024-02-14
Authors : Lazaar Hamza Meryem Sefrioui Taha Boutaj Manal Tabchi Boutayna Azarkan Akkoumi Abdelkader Saad Benchekroun Abdellah Amazouzi; Lalla Ouafa Cherkaoui;
Page : 463-466
Keywords : ;
Abstract
Central serous chorioretinopathy (CSCR) is characterized by a localized serous detachment of the neuroretina (DSR), associated with detachments of the retinal pigment epithelium (RPE) at the posterior pole [1]and a leakage of fluid in the subretinal space. Pregnancy, Type A personality, and systemic corticosteroid therapy are the main risk factors for Central Serous Chorioretinopathy [ 2] We report the case of a patient who developed central serous chorioretinopathy following the oral intake of 20mg tadalafil erectile dysfunction, suggesting a possible involvement of phosphodiesterase type 5 inhibitors as a risk factor for central serous chorioretinopathy.
Other Latest Articles
- KNOWLEDGE ATTITUDE AND AWARENESS REGARDING ZNO SUNSCREEN PROTECTION AMONG UNDERGRADUATE DENTAL STUDENTS
- CORRELATION OF SERUM LACTATE LEVELS WITH SURVIVAL IN PATIENTS WITH SEPSIS
- ADVANCING HEALTHCARE THROUGH CORPORATE SOCIAL RESPONSIBILITY: A CASE STUDY IN COIMBATORE DISTRICT
- A STUDY OF COMMERCIAL REAL ESTATE DEVELOPMENT IN BIHAR
- UNDERSTANDING MUSCLE CONTRACTION: MECHANISMS AND IMPLICATIONS
Last modified: 2024-03-11 13:23:09